Living With T1D/September 18, 2026/2 min read

How AI Is Reshaping Type 1 Diabetes Care—and What It Means for Your Doctor

Artificial intelligence is automating parts of diabetes management, but the evidence differs widely between Type 1 and Type 2. Here's what the science actually shows about the future of care.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

living with t1dmental healthtechnologysupport

Key takeaways

Automated insulin delivery systems for Type 1 diabetes have solid evidence backing their use
AI tools for Type 2 diabetes show promise but work best when doctors remain in control
Not all diabetes tasks are ready for full automation—evidence varies across different tools
Your healthcare team will likely continue to play a central role in your care, even as AI grows

What AI Can Already Do in Diabetes Care

Artificial intelligence is beginning to handle specific diabetes management tasks. For people with Type 1 diabetes, automated insulin delivery systems represent the clearest success story. These systems can now reliably adjust insulin doses, giving doctors and patients real help in day-to-day management.

For Type 2 diabetes, AI tools show potential in screening for complications and adjusting insulin doses. However, the evidence supporting these tools is less established than what we see in Type 1.

The Evidence Isn't Equal Across All Tools

One key finding from recent research is that AI's readiness varies significantly depending on what task it's performing. Automated insulin delivery in Type 1 diabetes has crossed the threshold from experimental to established practice.

For Type 2 diabetes, validated screening and insulin-adjustment tools exist, but researchers and clinicians recommend a tiered approach. This means AI supports decision-making rather than replacing human judgment. These tools work best when doctors review recommendations and remain actively involved in treatment decisions.

Your Doctor Isn't Going Anywhere

As AI takes on more routine diabetes tasks, the role of your healthcare team is evolving rather than disappearing. Even in cases where AI is most advanced, doctors bring context, experience, and personalized judgment that algorithms cannot replicate.

The emerging picture of 'algorithmic care' isn't about removing doctors from the equation. It's about using AI to handle repetitive, data-heavy work so your healthcare team can focus on what matters most: understanding your individual needs and goals.

What This Means for You

If you use an automated insulin delivery system for Type 1 diabetes, you're already benefiting from established AI technology. If you have Type 2 diabetes and your doctor mentions AI-assisted screening or dosing tools, ask how they plan to use those recommendations—your doctor should always be making the final call.

As these tools become more common, the quality of AI matters as much as its novelty. Not every tool has the same level of evidence behind it, so it's worth asking your healthcare team what evidence supports any new technology they recommend.

Evidence label

Source: PLOS digital health. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.